Acute facial paresis as a possible complication of vaccination against SARS-CoV-2
Thieme. All rights reserved..
Although acute facial nerve palsy (Bell's palsy) is explicitly mentioned in the information sheets for vaccines as a possible complication of vaccination against SARS-CoV-2, from our point of view the benefits of the vaccination clearly outweigh the possible risks. At most, if at all, a slightly increased risk can be derived from the previous case reports. In general, the risk of acute facial palsy is described in association with many vaccinations. The risk, if any, does not appear to be a specific risk of SARS-CoV-2 vaccines. On the other hand, cases of acute facial palsy as symptom of a COVID-19 disease have also been described, so that the theoretical question arises as to the extent to which the vaccination may prevent rather than promote the occurrence of facial palsy. Ultimately, if acted quickly, acute facial paralysis can be treated well and its severity and sequelae cannot be compared with the severity of a COVID-19 disease and its possible long-COVID sequelae.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
---|---|
Enthalten in: |
Laryngo- rhino- otologie - 100(2021), 7 vom: 01. Juli, Seite 526-528 |
Sprache: |
Deutsch |
---|
Weiterer Titel: |
Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 |
---|
Beteiligte Personen: |
Volk, Gerd Fabian [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 28.06.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/a-1501-0470 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM325269025 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM325269025 | ||
003 | DE-627 | ||
005 | 20231225192103.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||ger c | ||
024 | 7 | |a 10.1055/a-1501-0470 |2 doi | |
028 | 5 | 2 | |a pubmed24n1084.xml |
035 | |a (DE-627)NLM325269025 | ||
035 | |a (NLM)33975372 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ger | ||
100 | 1 | |a Volk, Gerd Fabian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acute facial paresis as a possible complication of vaccination against SARS-CoV-2 |
246 | 3 | 3 | |a Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.06.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a Although acute facial nerve palsy (Bell's palsy) is explicitly mentioned in the information sheets for vaccines as a possible complication of vaccination against SARS-CoV-2, from our point of view the benefits of the vaccination clearly outweigh the possible risks. At most, if at all, a slightly increased risk can be derived from the previous case reports. In general, the risk of acute facial palsy is described in association with many vaccinations. The risk, if any, does not appear to be a specific risk of SARS-CoV-2 vaccines. On the other hand, cases of acute facial palsy as symptom of a COVID-19 disease have also been described, so that the theoretical question arises as to the extent to which the vaccination may prevent rather than promote the occurrence of facial palsy. Ultimately, if acted quickly, acute facial paralysis can be treated well and its severity and sequelae cannot be compared with the severity of a COVID-19 disease and its possible long-COVID sequelae | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Kuttenreich, Anna-Maria |e verfasserin |4 aut | |
700 | 1 | |a Geitner, Maren |e verfasserin |4 aut | |
700 | 1 | |a Guntinas-Lichius, Orlando |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Laryngo- rhino- otologie |d 1995 |g 100(2021), 7 vom: 01. Juli, Seite 526-528 |w (DE-627)NLM012616737 |x 1438-8685 |7 nnns |
773 | 1 | 8 | |g volume:100 |g year:2021 |g number:7 |g day:01 |g month:07 |g pages:526-528 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1501-0470 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 100 |j 2021 |e 7 |b 01 |c 07 |h 526-528 |